A shotgun proteomic study of the protein corona associated with cholesterol and atheronal-B surface-modified quantum dots

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 77, Issue 3, 2011, Pages 353-359

  Prapainop, Kanlaya ^a   Wentworth Jr , Paul ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Cholesterol; Nanoparticles; Oxysterols; Protein corona; Proteomics; Quantum dots

Indexed keywords

AMINO ACID; ANTIBODY; BETA2 GLYCOPROTEIN; CHOLESTEROL; GLYCOPROTEIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXYSTEROL; QUANTUM DOT; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

AQUEOUS SOLUTION; ARTICLE; BINDING AFFINITY; FLUORESCENCE; HUMAN; HYDROPHOBICITY; LIGHT CHAIN; PROTEIN ANALYSIS; PROTEIN CORONA; PROTEIN STRUCTURE; SHOTGUN PROTEOMIC STUDY; SYNTHESIS;

BLOOD PROTEINS; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, AGAR GEL; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR STRUCTURE; PROTEIN BINDING; PROTEIN FOLDING; PROTEOMICS; QUANTUM DOTS; SPECTROMETRY, FLUORESCENCE; SURFACE PROPERTIES; TANDEM MASS SPECTROMETRY;

EID: 79952312613     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2010.12.026     Document Type: Article

References (34)

1. J.K. Jaiswal, S.M. Simon, Potentials and pitfalls of fluorescent quantum dots for biological imaging, Trends Cell Biol. 14 (2004) 497-504. (Pubitemid 39209357)
2. W.J. Parak, T. Pellegrino, C. Plank, Labelling of cells with quantum dots, Nanotechnology 16 (2005) R9-R25. (Pubitemid 40274841)
3. X. Michalet, F.F. Pinaud, L.A. Bentolila, J.M. Tsay, S. Doose, J.J. Li, G. Sundaresan, A.M. Wu, S.S. Gambhir, S. Weiss, Quantum dots for live cells, in vivo imaging, and diagnostics, Science 307 (2005) 538-544.
4. B. Ballou, B.C. Lagerholm, L.A. Ernst, M.P. Bruchez, A.S. Waggoner, Noinvasive imaging of quantum dots in mice, Bioconj. Chem. 15 (2004) 79-86.
5. E. Casals, T. Pfaller, A. Duschl, G.J. Oostingh, V. Puntes, Time evolution of the nanoparticle protein corona, ACS Nano 4 (2010) 3623-3632.
6. I.L. Medintz, H.T. Uyeda, E.R. Goldman, H. Mattoussi, Quantum dot bioconjugates for imaging, labelling and sensing, Nat. Mater. 4 (2005) 435-446. (Pubitemid 40774047)
7. S.H.D.P. Lacerda, J.J. Park, C. Meuse, D. Pristinski, M.L. Becker, A. Karim, J.F. Douglas, Interaction of gold nanoparticles with common human blood proteins, ACS Nano 4 (2009) 365-379.
8. T. Cedervall, I. Lynch, M. Foy, T. Berggård, Seamas C. Donnelly, G. Cagney, S. Linse, Kenneth A. Dawson, Detailed identification of plasma proteins adsorbed on copolymer nanoparticles, Angew. Chem. Int. Ed. 46 (2007) 5754-5756.
9. M. Lundqvist, J. Stigler, G. Elia, I. Lynch, T. Cedervall, K.A. Dawson, Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts, Proc. Nat. Acad. Sci. USA 105 (2008) 14265-14270.
10. P. Wentworth Jr., J. Nieva, C. Takeuchi, R. Galve, A.D. Wentworth, R.B. Dilley, G.A. DeLaria, A. Saven, B.M. Babior, K.D. Janda, A. Eschenmoser, R.A. Lerner, Evidence for ozone formation in human atherosclerotic arteries, Science 302 (2003) 1053-1056. (Pubitemid 37386200)
11. Q. Zhang, E.T. Powers, J. Nieva, M.E. Huff, M.A. Dendle, J. Bieschke, C.G. Glabe, A. Eschenmoser, P. Wentworth Jr., R.A. Lerner, J.W. Kelly, Metabolite-initiated protein misfolding may trigger Alzheimer's disease, Proc. Nat. Acad. Sci. USA 101 (2004) 4752-4757. (Pubitemid 38469149)
12. C. Takeuchi, R. Galve, J. Nieva, D.P. Witter, A.D. Wentworth, R.P. Troseth, R.A. Lerner, P. Wentworth Jr., Proatherogenic effects of the cholesterol ozonolysis products, atheronal-A and atheronal-B, Biochemistry 45 (2006) 7162-7170. (Pubitemid 43877405)
13. J.C. Scheinost, H. Wang, G. Boldt, J. Offer, P. Wentworth Jr., Cholesterol secosterol-induced aggregation of methylated amyloid-beta peptides - insights into aldehyde-initiated fibrillization of amyloid-beta, Angew. Chem. Int. Ed. 47 (2008) 3919-3922.
14. D.A. Bosco, D.M. Fowler, Q. Zhang, J. Nieva, E.T. Powers, P. Wentworth Jr., R.A. Lerner, J.W. Kelly, Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization, Nat. Chem. Biol. 2 (2006) 249-253.
15. J. Nieva, A. Shafton, L.J. Altobell, S. Tripuraneni, J.K. Rogel, A.D. Wentworth, R.A. Lerner, P. Wentworth, Lipid-derived aldehydes accelerate light chain amyloid and amorphous aggregation, Biochemistry 47 (2008) 7695-7705. (Pubitemid 352019500)
16. J.C. Scheinost, D.P. Witter, G.E. Boldt, J. Offer, P.J. Wentworth, Cholesterol secosterol adduction inhibits the misfolding of a mutant prion protein fragment that induces neurodegeneration, Angew. Chem. Int. Ed. 48 (2009) 9469-9472.
17. R.W. Mahley, T.L. Innerarity, S.C. Rall, K.H. Weisgraber, Plasma lipoproteins: apolipoprotein structure and function, J. Lipid Res. 25 (1984) 1277-1294. (Pubitemid 15150638)
18. P. Alaupovic, Apolioproteins and lipoproteins, Atherosclerosis 13 (1971) 141-146.
19. I. Lynch, T. Cedervall, M. Lundqvist, C. Cabaleiro-Lago, S. Linse, K.A. Dawson, The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century, Adv. Colloid Interf. Sci. 134-135 (2007) 167-174.
20. I. Lynch, T. Cedervall, M. Lundqvist, C. Cabaleiro-Lago, S. Linse, K.A. Dawson, The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century, Adv. Colloid Interf. Sci. 134-135 (2007) 167-174.
21. E.M. Marcotte, How do shotgun proteomics algorithms identify proteins?, Nat Biotechnol. 25 (2007) 755-757. (Pubitemid 47053867)
22. H.V. de Silva, W.D. Stuart, C.R. Duvic, J.R. Wetterau, M.J. Ray, D.G. Ferguson, H.W. Albers, W.R. Smith, J.A. Harmony, A 70-kDa apolipoprotein designated Apo J is a marker for subclasses of human plasma high density lipoproteins, J. Biol. Chem. 265 (1990) 13240-13247.
23. D.E. Jenne, J. Tschopp, Clusterin: the intriguing guises of a widely expressed glycoprotein, Trends Biochem. Sci. 17 (1992) 154-159.
24. I.C. Gelissen, T. Hochgrebe, M.R. Wilson, S.B. Easterbrook-Smith, W. Jessup, R.T. Dean, A.J. Brown, Apolipoprotein J (clusterin) induces cholesterol export from macrophage-foam cells: a potential anti-atherogenic function?, Biochem J. 331 (1998) 231-237. (Pubitemid 28163979)
25. J. Krøll, J.K. Larsen, H. Loft, M. Ezban, K. Wallevik, M. Faber, DNA-binding proteins in Yoshida ascites tumor fluid, Biochim. Biophys. Acta 434 (1976) 490-501.
26. J.S. Liang, J.D. Sipe, Recombinant human serum amyloid A (apoSAAp) binds cholesterol and modulates cholesterol flux, J. Lipid Res. 36 (1995) 37-46.
27. E. Hellstrand, I. Lynch, A. Andersson, T. Drakenberg, B. Dahlback, K.A. Dawson, S. Linse, T. Cedervall, Complete high-density lipoprotein in nanoparticle corona, FEBS 276 (2009) 3372-3381.
28. H.P. McNeil, R.J. Simpson, C.N. Chesterman, S.A. Krilis, Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H), Proc. Nat. Acad. Sci. USA 87 (1990) 4120-4124.
29. I. Schousboe, Beta 2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway, Blood 66 (1985) 1086-1091. (Pubitemid 16250272)
30. T. Vaisar, S. Pennathur, P.S. Green, S.A. Gharib, A.N. Hoofnagle, M.C. Cheung, J. Byun, S. Vuletic, S. Kassim, P. Singh, H. Chea, R.H. Knopp, J. Brunzell, R. Geary, A. Chait, X.-Q. Zhao, K. Elkon, S. Marcovina, P. Ridker, J.F. Oram, J.W. Heinecke, Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL, J. Clin. Invest. 117 (2007) 746-756.
31. J.W. Heinecke, The HDL proteome: a marker - and perhaps mediator - of coronary artery disease, J. Lipid Res. 50 (2009) S167-S171.
32. R.C. Wiggins, B.N. Bouma, C.G. Cochrane, J.H. Griffin, Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein, Proc. Nat. Acad. Sci. USA 74 (1977) 4636-4640. (Pubitemid 8225181)
33. C. Salvador-Morales, E. Flahaut, E. Sim, J. Sloan, M.L. Green, R.B. Sim, Complement activation and protein adsorption by carbon nanotubes, Mol. Immunol. 43 (2006) 193-201.
34. C. Salvador-Morales, E. Flahaut, E. Sim, J. Sloan, M.L.H. Green, R.B. Sim, Complement activation and protein adsorption by carbon nanotubes, Mol. Immunol. 43 (2006) 193-201.